These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6324144)

  • 1. Effects of CCK-8 in the nucleus accumbens.
    DeFrance JF; Sikes RW; Chronister RB
    Peptides; 1984; 5(1):1-6. PubMed ID: 6324144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioral interaction between endogenous opioids, CCK-8 and dopaminergic systems in the nucleus accumbens of rats.
    van Ree JM; Igarashi J; Király I
    NIDA Res Monogr; 1986; 75():323-6. PubMed ID: 2448632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does cholecystokinin potentiate dopamine action in the nucleus accumbens?
    Wang RY; Hu XT
    Brain Res; 1986 Aug; 380(2):363-7. PubMed ID: 3756487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral evidence for cholecystokinin modulation of dopamine in the mesolimbic pathway.
    Crawley JH
    Prog Clin Biol Res; 1985; 192():131-8. PubMed ID: 4080706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of dopamine agonists on excitatory inputs to nucleus accumbens neurons from the amygdala: modulatory actions of cholecystokinin.
    Liang RZ; Wu M; Yim CC; Mogenson GJ
    Brain Res; 1991 Jul; 554(1-2):85-94. PubMed ID: 1681991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topographical analysis of nucleus accumbens sites at which cholecystokinin potentiates dopamine-induced hyperlocomotion in the rat.
    Crawley JN; Hommer DW; Skirboll LR
    Brain Res; 1985 Jun; 335(2):337-41. PubMed ID: 4005562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions of cholecystokinin octapeptide and dopamine on nucleus accumbens neurons.
    White FJ; Wang RY
    Brain Res; 1984 May; 300(1):161-6. PubMed ID: 6145498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleus accumbens cholecystokinin (CCK) can either attenuate or potentiate amphetamine-induced locomotor activity: evidence for rostral-caudal differences in accumbens CCK function.
    Vaccarino FJ; Rankin J
    Behav Neurosci; 1989 Aug; 103(4):831-6. PubMed ID: 2765186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral evidence for the involvement of endogenous opioids in the interaction between cholecystokinin and brain dopamine systems.
    Király I; Van Ree JM
    Neurosci Lett; 1987 Mar; 74(3):343-7. PubMed ID: 3561887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuromodulatory action of dopamine in the nucleus accumbens: an in vivo intracellular study.
    Yim CY; Mogenson GJ
    Neuroscience; 1988 Aug; 26(2):403-15. PubMed ID: 3173682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrophysiological effects of cholecystokinin: central dopaminergic systems.
    Wang RY; White FJ
    Prog Clin Biol Res; 1985; 192():95-103. PubMed ID: 4080721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholecystokinin antagonist lorglumide reverses chronic haloperidol-induced effects on dopamine neurons.
    Jiang LH; Kasser RJ; Wang RY
    Brain Res; 1988 Nov; 473(1):165-8. PubMed ID: 3208120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrophysiological evidence of modulatory interaction between dopamine and cholecystokinin in the nucleus accumbens.
    Yim CC; Mogenson GJ
    Brain Res; 1991 Feb; 541(1):12-20. PubMed ID: 2029612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response of ventral pallidal neurons to amygdala stimulation and its modulation by dopamine projections to nucleus accumbens.
    Yim CY; Mogenson GJ
    J Neurophysiol; 1983 Jul; 50(1):148-61. PubMed ID: 6875644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of fimbria input to nucleus accumbens.
    DeFrance JF; Marchand JF; Sikes RW; Chronister RB; Hubbard JI
    J Neurophysiol; 1985 Dec; 54(6):1553-67. PubMed ID: 2418171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine action in the nucleus accumbens.
    DeFrance JF; Sikes RW; Chronister RB
    J Neurophysiol; 1985 Dec; 54(6):1568-77. PubMed ID: 3003262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of cholecystokinin (CCK-8) on dopamine-containing nerve terminals in the caudate nucleus and nucleus accumbens of the anesthetized rat: an in vivo electrochemical study.
    Gerhardt GA; Friedemann M; Brodie MS; Vickroy TW; Gratton AP; Hoffer BJ; Rose GM
    Brain Res; 1989 Oct; 499(1):157-63. PubMed ID: 2804664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of dopamine on limbic inputs to the nucleus accumbens.
    Mogenson GJ; Yang CR; Yim CY
    Ann N Y Acad Sci; 1988; 537():86-100. PubMed ID: 3059937
    [No Abstract]   [Full Text] [Related]  

  • 19. Hippocampal signal transmission to the pedunculopontine nucleus and its regulation by dopamine D2 receptors in the nucleus accumbens: an electrophysiological and behavioural study.
    Yang CR; Mogenson GJ
    Neuroscience; 1987 Dec; 23(3):1041-55. PubMed ID: 2963972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCK activates excitatory ventral tegmental pathways to the posterior nucleus accumbens.
    Tanaka J; Kariya K; Ushigome A; Matsuda M; Nomura M
    Neuroreport; 1994 Dec; 5(18):2558-60. PubMed ID: 7696603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.